Upload File

cost-effectiveness of denosumab versus zoledronic acid (za) for the prevention of skeletal-related...

  • Home
  • Health & Medicine
  • Cost-effectiveness of denosumab versus zoledronic acid (za) for the prevention of skeletal-related events (SRE) in patients with bone metastases (BM) from castration-resistant prostate
1

Upload: htai-bilbao-2012

Post on 29-Nov-2014

676 views

Category:

Health & Medicine


9 download

Report

DESCRIPTION

Lothgren M, Bracco A, Lundkvist J, Biteeva I, Schwenkglenks M, Cristino J, Pereira J, Northridge K, Halperin M, Macarios D, Chung K, Danese MD. Cost-effectiveness of denosumab versus zoledronic acid (za) for the prevention of skeletal-related events (SRE) in patients with bone metastases (BM) from castration-resistant prostate cancer (CRPC) Sweden, Switzerland and Portugal. Presented at the 9th Annual HTAi meeting 2012 (Spain Bilbao 25-27 June 2012). Abstract published in Gaceta Sanitaria 2012, Vol. 26 Especial Congreso 2 – Junio 2012: 282.

TRANSCRIPT

Page 1: Cost-effectiveness of denosumab versus zoledronic acid (za) for the prevention of skeletal-related events (SRE) in patients with bone metastases (BM) from castration-resistant prostate

Effect of Denosumab versus Zoledronic Acid Treatment in Patients with Breast Cancer and Bone Metastases: Results from the Extended Blinded Treatment Phase

ZOMETA® (zoledronic acid)

How chemical castration works

Novartis Pharmaceuticals Corporation RECLAST- zoledronic

Zometa (zoledronic acid) prescribing ... - Novartis US · ZOMETA® (zoledronic acid) injection, ... To report SUSPECTED ADVERSE REACTIONS, ... Follow proper aseptic technique

PRODUCT MONOGRAPH PrZOLEDRONIC ACID … MONOGRAPH Pr ZOLEDRONIC ACID INJECTION 5 mg/100 mL zoledronic acid (as zoledronic acid monohydrate) Solution …

Denosumab vs bisfosfonato en metástasis óseas

Stärke, The Castration Complex

ZOMETA® (zoledronic acid) OF THE DRUG

AnAntibodyTargetingtheTypeIInsulin-likeGrowthFactorReceptor … · castration. In groups 2 and 3, tumor volumes nadired 6 weeks after castration at

TARO-ZOLEDRONIC ACID (Zoledronic acid Injection) · 2018. 1. 25. · Overall incidence of atrial fibrillation in the 3-year postmenopausal osteoporosis trial (HORIZON-PFT) using zoledronic

Castration Photos

Denosumab Induces Tumor Reduction and Bone Formation …clincancerres.aacrjournals.org/content/clincanres/18/16/4415.full.pdf · Cancer Therapy: Clinical Denosumab Induces Tumor Reduction

Severe hepatocytotoxicity linked to denosumab

Denosumab Induces Tumor Reduction and Bone Formation in ... · denosumab in reducing tumor-associated bone lysis. The safety and efficacy of denosumab in this study have been described

Equine Castration AU Vet Journal

Castration-induced Apoptosis of Androgen-dependent ... · castration-induced apoptosis. Tumor tissues were harvested 3, 8, and 10 days after castration. Quantitation of Apoptosis

osucowcamp.okstate.eduosucowcamp.okstate.edu/cow-calf-boot-camp/2015-camp...ORDER NO.07-029 JUNE 2007 AGDEX 420/26 CASTRATION OF CALVES N. Anderson CASTRATION DEFINED Castration of

TARO-ZOLEDRONIC ACID (Zoledronic acid Injection)rxproduct.taro.ca/media/oMedia/TARO-ZOLEDRONICACIDFinalPM.pdf · Product Monograph: Taro-Zoledronic Acid (5 mg/100mL) Page 3 of 38

Akorn, Inc. ZOLEDRONIC ACID- zoledronic acid solution

Zoledronic acid - Therapeutic Goods Administration

Australian public assessment report for Darolutamide · Web viewSmith MR et al. (2013). Denosumab and bone metastasis-free survival in men with nonmetastatic castration-resistant

PPT - Zoledronic Acid: Development Overview

Castration - Animal Welfare Standards

Zoledronic Acid Audit

Advanced Prostate Cancer...Prostate cancer is castration sensitive when it responds to chemical castration. Treatments are available for metastatic castration-sensitive prostate cancer

Zoledronic acid Mylan, INN-zoledronic acid€¦ · EMA/550636/2012 . Committee for Medicinal Products for Human Use (CHMP) Assessment report . Zoledronic acid Mylan . ... (EU/1/01/176/007-009)

Breast Cancer and Bone. Charles Shapiro.pdf · CANCER: Breast cancer bone metastases: denosumab or zoledronic acid? Gabri van der Pluijm Abstract Bone metastases cause patient morbidity

NAME OF THE MEDICINE · Dmab (N = 886) Study 20050103 ZA (N = 951) Dmab (N = 950) ZA - Zoledronic Acid 4 mg Q4W Dmab - Denosumab 120 mg Q4W Proportion of Subjects Without On-study

Castration-Resistant Prostate Cancer (CRPC): evaluation …cc-arcc.ca/.../06/Castration-resistant-prostate-cancer-LAHCENE.pdf · castration-resistant prostate cancer (crpc): evaluation

AUSTRALIAN PRODUCT INFORMATION - ACLASTA (zoledronic acid

Normal and Cryptorchid Castration

Denosumab Safety FDA Analysis - University of Washingtoncourses.washington.edu/bonephys/denosumab/Rothstein... · the anticipated calcium nadir (8-11 days post- dose) • One denosumab-treated

SHEEP STANDARDS AND GUIDELINES CASTRATION … · Sheep castration discussion paper public consultation version 1.3.13 Page 1 of 12 SHEEP STANDARDS AND GUIDELINES – CASTRATION DISCUSSION

PRODUCT MONOGRAPH PrZOLEDRONIC ACID INJECTION · PRODUCT MONOGRAPH . Pr ZOLEDRONIC ACID INJECTION. 5 mg/100 mL zoledronic acid (as zoledronic acid monohydrate) Solution for intravenous